Skip to main content
. 2022 May 16;12:8039. doi: 10.1038/s41598-022-12072-0

Figure 2.

Figure 2

Expression of TPD52, PKCε, KLF14 and miRNA124 in relation to tumor grade of brain cancer. (A) Expression of TPD52 in grade I + II and III + IV compared to healthy controls; (B) Expression of PKCε in grade I + II and III + IV patients compared to healthy controls; (C) Expression of KLF14 grade I + II and III + IV patients compared to healthy controls; (D) Expression of miRNA 124 in grade I + II and III + IV compared to healthy controls; Representative data are presented as mean ± SEM of triplicate experiments. Statistical significance was measured by one way Anova (****P < 0.0001).